EMBER: A RNA-Based Tool for Breast Cancer Diagnosis and Treatment – The Institute of Cancer Research
The Institute of Cancer Research shared a post on LinkedIn:
“A New tool, EMBER, could revolutionise the diagnosis and treatment of the most common type of Breast Cancer.
A team led by scientists at the ICR has found a way to combine different types of RNA datasets, creating a space that serves as a reference point for new patient samples.
The localisation of a new patient’s profile in the EMBER space allows researchers to get additional biological information about the tumour’s biology. This makes it easier to predict how the cancer will respond to endocrine therapy.
Dr Syed Haider, Group Leader of the Breast Cancer Research Bioinformatics group at the ICR, said:
“Now, in theory, any time a patient is diagnosed with breast cancer and RNA sequencing can be performed on their biopsy, the sample can be placed in the EMBER space, and different prognostic and predictive factors can be determined. Until now, this has not been feasible.”“
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023